Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Drug Resistance

  Free Subscription


Articles published in J Antimicrob Chemother

Retrieve available abstracts of 341 articles:
HTML format



Single Articles


    June 2022
  1. MITCHELL J, O'Neill AJ, King R
    Creating a framework to align antimicrobial resistance (AMR) research with the global guidance: a viewpoint.
    J Antimicrob Chemother. 2022 Jun 24. pii: 6617339. doi: 10.1093.
    PubMed     Abstract available


  2. GINEVRA C, Beraud L, Pionnier I, Sallabery K, et al
    Detection of highly macrolide-resistant Legionella pneumophila strains from a hotel water network using systematic whole-genome sequencing.
    J Antimicrob Chemother. 2022 Jun 9. pii: 6604636. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  3. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of an MDR Lactobacillus salivarius isolate harbouring the phenicol-oxazolidinone-tetracycline resistance gene poxtA.
    J Antimicrob Chemother. 2022 May 31. pii: 6595591. doi: 10.1093.
    PubMed     Abstract available


  4. SULIS G, Pai M, Gandra S
    Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 May 31. pii: 6595593. doi: 10.1093.
    PubMed    


  5. NAHA S, Sands K, Mukherjee S, Dutta S, et al
    A 12 year experience of colistin resistance in Klebsiella pneumoniae causing neonatal sepsis: two-component systems, efflux pumps, lipopolysaccharide modification and comparative phylogenomics.
    J Antimicrob Chemother. 2022;77:1586-1591.
    PubMed     Abstract available


  6. LIU P, Qin X, Cao T, Yang Y, et al
    Telithromycin resistance in Campylobacter mediated by 23S rRNA A2075G mutation and erm(B).
    J Antimicrob Chemother. 2022;77:1557-1560.
    PubMed     Abstract available


  7. REVOLLO B, Vinuela L, de la Mora L, Garcia F, et al
    Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression.
    J Antimicrob Chemother. 2022;77:1738-1740.
    PubMed     Abstract available


  8. JAUNEIKAITE E, Honeyford K, Blandy O, Mosavie M, et al
    Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.
    J Antimicrob Chemother. 2022;77:1753-1761.
    PubMed     Abstract available


  9. LUQUE-PAZ D, Bennis Y, Jaubert P, Dubee V, et al
    Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis.
    J Antimicrob Chemother. 2022;77:1787-1789.
    PubMed    


  10. OUESLATI S, Raymond J, Croue M, Carvahlo L, et al
    MDR bacterial isolates in environmental samples from Kinshasa, Democratic Republic of the Congo.
    J Antimicrob Chemother. 2022;77:1785-1787.
    PubMed    


  11. IWUJI C, Pillay D, Shamu P, Murire M, et al
    A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa.
    J Antimicrob Chemother. 2022 May 17. pii: 6586623. doi: 10.1093.
    PubMed     Abstract available


  12. BRAZIER A, Merriam S, Halpern D
    BSAC Vanguard Series: Behavioural science and antimicrobial resistance.
    J Antimicrob Chemother. 2022 May 16. pii: 6586211. doi: 10.1093.
    PubMed     Abstract available


  13. GOLPARIAN D, Kittiyaowamarn R, Paopang P, Sangprasert P, et al
    Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018.
    J Antimicrob Chemother. 2022 May 11. pii: 6583486. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  14. ZHANG X, Shi S, Yao Z, Zheng X, et al
    Antimicrobial peptide WAM-1: a promising antibacterial and anti-inflammatory drug against carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 27. pii: 6574685. doi: 10.1093.
    PubMed     Abstract available


  15. BARENG OT, Moyo S, Zahralban-Steele M, Maruapula D, et al
    HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana.
    J Antimicrob Chemother. 2022;77:1385-1395.
    PubMed     Abstract available


  16. GUPTA A, Landman D, Quale J
    Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2022;77:1282-1285.
    PubMed     Abstract available


  17. PACIOS O, Fernandez-Garcia L, Bleriot I, Blasco L, et al
    Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-beta-naphthylamide (PabetaN): co-resistance to antimicrobials.
    J Antimicrob Chemother. 2022;77:1272-1281.
    PubMed     Abstract available


  18. YANG D, Heederik DJJ, Scherpenisse P, Van Gompel L, et al
    Antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) abundance in animal faeces, meat, production environments and human faeces in Europe.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573562. doi: 10.1093.
    PubMed     Abstract available


  19. CHAGNEAU CV, Alcouffe O, Grare M, Oswald E, et al
    Screening for beta-lactam resistance by penicillin G in the Streptococcus anginosus group challenged by rare strains with altered PBPs.
    J Antimicrob Chemother. 2022 Apr 25. pii: 6573466. doi: 10.1093.
    PubMed     Abstract available


  20. LIU C, Dong N, Zeng Y, Lu J, et al
    Co-transfer of last-line antibiotic resistance and virulence operons by an IncFIBk-FII-X3-ColKP3 hybrid plasmid in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571571. doi: 10.1093.
    PubMed     Abstract available


  21. SCHWENDENER S, Perreten V
    The bla and mec families of beta-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococcus.
    J Antimicrob Chemother. 2022 Apr 21. pii: 6571732. doi: 10.1093.
    PubMed     Abstract available


  22. SCHINK AK, Hanke D, Semmler T, Brombach J, et al
    Novel multiresistance-mediating integrative and conjugative elements carrying unusual antimicrobial resistance genes in Mannheimia haemolytica and Pasteurella multocida.
    J Antimicrob Chemother. 2022 Apr 18. pii: 6569420. doi: 10.1093.
    PubMed    


  23. CORTES MF, Andre C, Martins Simoes P, Corvec S, et al
    Persistence of a multidrug-resistant worldwide-disseminated methicillin-resistant Staphylococcus epidermidis clone harbouring the cfr linezolid resistance gene in a French hospital with evidence of interspecies transfer to several Staphylococcus aureu
    J Antimicrob Chemother. 2022 Apr 15. pii: 6568602. doi: 10.1093.
    PubMed     Abstract available


  24. FUCHS F, Becerra-Aparicio F, Xanthopoulou K, Seifert H, et al
    In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    J Antimicrob Chemother. 2022 Apr 12. pii: 6566767. doi: 10.1093.
    PubMed     Abstract available


  25. HARMER CJ, Lebreton F, Stam J, McGann PT, et al
    Complete genome of the extensively antibiotic-resistant GC1 Acinetobacter baumannii isolate MRSN 56 reveals a novel route to fluoroquinolone resistance.
    J Antimicrob Chemother. 2022 Apr 11. pii: 6566059. doi: 10.1093.
    PubMed     Abstract available


  26. CHARANI E
    BSAC Vanguard Series: Why culture matters to tackle antibiotic resistance.
    J Antimicrob Chemother. 2022 Apr 6. pii: 6564004. doi: 10.1093.
    PubMed     Abstract available


  27. CHAIBEN V, Yamada CH, Telles JP, de Andrade AP, et al
    A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam.
    J Antimicrob Chemother. 2022 Apr 4. pii: 6562691. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  28. SUN Z, Lan Y, Liang S, Wang J, et al
    Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.
    J Antimicrob Chemother. 2022;77:1119-1124.
    PubMed     Abstract available


  29. GOMIS-FONT MA, Cabot G, Lopez-Arguello S, Zamorano L, et al
    Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
    J Antimicrob Chemother. 2022;77:957-968.
    PubMed     Abstract available


  30. CHEUNG PK, Shahid A, Dong W, Lepik KJ, et al
    Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
    J Antimicrob Chemother. 2022;77:979-988.
    PubMed     Abstract available


  31. REYNOLDS R, Mushtaq S, Allen MK, Horner C, et al
    Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance.
    J Antimicrob Chemother. 2022;77:1206-1208.
    PubMed    


  32. AMBROSE SJ, Hamidian M, Hall RM
    Extensively resistant Acinetobacter baumannii isolate RCH52 carries several resistance genes derived from an IncC plasmid.
    J Antimicrob Chemother. 2022;77:930-933.
    PubMed     Abstract available


  33. ZHU Y, Yang W, Schwarz S, Xu Q, et al
    Characterization of the novel optrA-carrying pseudo-compound transposon Tn7363 and an Inc18 plasmid carrying cfr(D) in Vagococcus lutrae.
    J Antimicrob Chemother. 2022;77:921-925.
    PubMed     Abstract available


  34. MARGOT N, Vanderveen L, Naik V, Ram R, et al
    Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study.
    J Antimicrob Chemother. 2022;77:989-995.
    PubMed     Abstract available


  35. GOFF D
    BSAC Vanguard Series: The future of antibiotic stewardship-managing access and excess.
    J Antimicrob Chemother. 2022;77:863-864.
    PubMed     Abstract available


  36. TICKNER JA, Bradshaw CS, Murray GL, Whiley DM, et al
    Novel probe-based melting curve assays for the characterization of fluoroquinolone resistance in Mycoplasma genitalium.
    J Antimicrob Chemother. 2022 Mar 30. pii: 6555777. doi: 10.1093.
    PubMed     Abstract available


  37. LIANG J, Macesic N, Blakeway L
    Comment on: Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2022 Mar 24. pii: 6553323. doi: 10.1093.
    PubMed    


  38. GEORGIOU PC, Arendrup MC, Meletiadis J
    Early phenotypic detection of fluconazole- and anidulafungin-resistant Candida glabrata isolates.
    J Antimicrob Chemother. 2022 Mar 22. pii: 6551886. doi: 10.1093.
    PubMed     Abstract available


  39. KIRCHHOFF L, Dittmer S, Furnica DT, Buer J, et al
    Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    J Antimicrob Chemother. 2022 Mar 15. pii: 6548677. doi: 10.1093.
    PubMed     Abstract available


  40. CREMANNS M, Lange F, Gatermann SG, Pfennigwerth N, et al
    Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022 Mar 10. pii: 6546017. doi: 10.1093.
    PubMed     Abstract available


  41. NEVILLE LF, Shalit I, Warn PA, Rendell JT, et al
    Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    J Antimicrob Chemother. 2022 Mar 1. pii: 6539950. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  42. DUBEY V, Devnath K, Gupta VK, Kalyan G, et al
    Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.
    J Antimicrob Chemother. 2022 Feb 24. pii: 6535191. doi: 10.1093.
    PubMed     Abstract available


  43. YAN L, Yu F, Liang J, Cheng Y, et al
    Drug resistance profiles and influencing factors among HIV-infected children and adolescents receiving long-term ART: a multicentre observational study in China.
    J Antimicrob Chemother. 2022;77:727-734.
    PubMed     Abstract available


  44. ELIAS P, Barraud O, El Hamel C, Chainier D, et al
    Integron detection for prediction of trimethoprim/sulfamethoxazole susceptibility in children with Enterobacterales urinary tract infections.
    J Antimicrob Chemother. 2022;77:767-770.
    PubMed     Abstract available


  45. ALIABADI S, Jauneikaite E, Muller-Pebody B, Hope R, et al
    Exploring temporal trends and risk factors for resistance in Escherichia coli-causing bacteraemia in England between 2013 and 2018: an ecological study.
    J Antimicrob Chemother. 2022;77:782-792.
    PubMed     Abstract available


  46. MARTELLI F, AbuOun M, Cawthraw S, Storey N, et al
    Detection of the transferable tigecycline resistance gene tet(X4) in Escherichia coli from pigs in the United Kingdom.
    J Antimicrob Chemother. 2022;77:846-848.
    PubMed    


  47. LUO H, Chen W, Mai Z, Yang J, et al
    Development and application of Cas13a-based diagnostic assay for Neisseria gonorrhoeae detection and azithromycin resistance identification.
    J Antimicrob Chemother. 2022;77:656-664.
    PubMed     Abstract available


  48. HACHIYA A, Kubota M, Shigemi U, Ode H, et al
    Specific mutations in the HIV-1 G-tract of the 3'-polypurine tract cause resistance to integrase strand transfer inhibitors.
    J Antimicrob Chemother. 2022;77:574-577.
    PubMed     Abstract available


  49. LOPEZ-DIAZ M, Ellaby N, Turton J, Woodford N, et al
    NDM-1 carbapenemase resistance gene vehicles emergent on distinct plasmid backbones from the IncL/M family.
    J Antimicrob Chemother. 2022;77:620-624.
    PubMed     Abstract available


  50. MELETIADIS J, Efstathiou I, van der Lee HAL, Astvad KMT, et al
    Spectrophotometric detection of azole-resistant Aspergillus fumigatus with the EUCAST broth microdilution method: is it time for automated MIC reading of EUCAST antifungal susceptibility testing of Aspergillus species?
    J Antimicrob Chemother. 2022 Feb 23. pii: 6534628. doi: 10.1093.
    PubMed     Abstract available


  51. KHOUJA T, Mitsantisuk K, Tadrous M, Suda KJ, et al
    Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19).
    J Antimicrob Chemother. 2022 Feb 18. pii: 6530407. doi: 10.1093.
    PubMed     Abstract available


  52. KELLY J, Tysall L, Dewar S
    Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528651. doi: 10.1093.
    PubMed     Abstract available


  53. DARLOW CA, Farrington N, Johnson A, McEntee L, et al
    Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6529341. doi: 10.1093.
    PubMed     Abstract available


  54. SHI S, Zhang X, Yao Z, Xu M, et al
    Synergistic effect of the novel beta-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2022 Feb 15. pii: 6528648. doi: 10.1093.
    PubMed     Abstract available


  55. CHUANG YC, Tseng TC, Wang JT, Lin CY, et al
    Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    J Antimicrob Chemother. 2022 Feb 10. pii: 6525717. doi: 10.1093.
    PubMed     Abstract available


  56. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2022;77:320-330.
    PubMed     Abstract available


  57. MENDELSON M
    BSAC Vanguard Series: Inequality and antibiotic resistance.
    J Antimicrob Chemother. 2022;77:277-278.
    PubMed     Abstract available


  58. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  59. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2022;77:400-408.
    PubMed     Abstract available


  60. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2022;77:356-363.
    PubMed     Abstract available


  61. HENERICO S, Mikasi SG, Kalluvya SE, Brauner JM, et al
    Prevalence and patterns of HIV drug resistance in patients with suspected virological failure in North-Western Tanzania.
    J Antimicrob Chemother. 2022;77:483-491.
    PubMed     Abstract available


  62. DUAN Y, Liu S, Gao Y, Zhang P, et al
    Macrolides mediate transcriptional activation of the msr(E)-mph(E) operon through histone-like nucleoid-structuring protein (HNS) and cAMP receptor protein (CRP).
    J Antimicrob Chemother. 2022;77:391-399.
    PubMed     Abstract available


  63. CASALONE E, Vignolini T, Braconi L, Gardini L, et al
    Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps.
    J Antimicrob Chemother. 2022;77:413-424.
    PubMed     Abstract available


  64. EL BOUZIDI K, Datir RP, Kwaghe V, Roy S, et al
    Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.
    J Antimicrob Chemother. 2022;77:474-482.
    PubMed     Abstract available


  65. LE HINGRAT Q, Collin G, Damond F, Peytavin G, et al
    In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
    J Antimicrob Chemother. 2022;77:409-412.
    PubMed     Abstract available


  66. SCHUSTER CF, Weber RE, Weig M, Werner G, et al
    Ultra-deep long-read sequencing detects IS-mediated gene duplications as a potential trigger to generate arrays of resistance genes and a mechanism to induce novel gene variants such as blaCTX-M-243.
    J Antimicrob Chemother. 2022;77:381-390.
    PubMed     Abstract available


  67. KANESAKA I, Ohno A, Katsuse AK, Takahashi H, et al
    The emergence of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone by transfer of resistance from an oral Neisseria subflava reservoir of resistance.
    J Antimicrob Chemother. 2022;77:364-373.
    PubMed     Abstract available


    January 2022
  68. AMBROSE SJ, Evans BA, Hall RM
    Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
    J Antimicrob Chemother. 2022 Jan 30. pii: 6517523. doi: 10.1093.
    PubMed    


  69. SHINTANI M, Suzuki H, Nojiri H, Suzuki M, et al
    Precise classification of antimicrobial resistance-associated IncP-2 megaplasmids for molecular epidemiological studies on Pseudomonas species.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515317. doi: 10.1093.
    PubMed    


  70. FRENK S, Temkin E, Lurie-Weinberger MN, Keren-Paz A, et al
    Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
    J Antimicrob Chemother. 2022 Jan 25. pii: 6515327. doi: 10.1093.
    PubMed     Abstract available


  71. YANG D, Heederik DJJ, Mevius DJ, Scherpenisse P, et al
    Risk factors for the abundance of antimicrobial resistance genes aph(3')-III, erm(B), sul2 and tet(W) in pig and broiler faeces in nine European countries.
    J Antimicrob Chemother. 2022 Jan 21. pii: 6513516. doi: 10.1093.
    PubMed     Abstract available


  72. PAUNKOV A, Gutenbrunner K, Soki J, Leitsch D, et al
    Haemin deprivation renders Bacteroides fragilis hypersusceptible to metronidazole and cancels high-level metronidazole resistance.
    J Antimicrob Chemother. 2022 Jan 18. pii: 6510936. doi: 10.1093.
    PubMed     Abstract available


  73. MADER R, Bourely C, Amat JP, Broens EM, et al
    Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach.
    J Antimicrob Chemother. 2022 Jan 12. pii: 6504034. doi: 10.1093.
    PubMed     Abstract available


  74. GAILLARD T, Dupieux-Chabert C, Butin M, Dumitrescu O, et al
    Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503862. doi: 10.1093.
    PubMed     Abstract available


  75. WELLS D
    BSAC Vanguard Series: The future role of laboratories in relation to antimicrobial resistance.
    J Antimicrob Chemother. 2022 Jan 11. pii: 6503859. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  76. ESSACK S
    BSAC Vanguard Series: From treatment options to precision medicine: the future of 'omics-based' antibiotic resistance surveillance data.
    J Antimicrob Chemother. 2021;77:5-6.
    PubMed     Abstract available


  77. OSTERHOLM MT
    BSAC Vanguard Series: the future of ADVOCACY on AMR.
    J Antimicrob Chemother. 2021;77:1-2.
    PubMed     Abstract available


  78. BERMAN D, Neale R
    BSAC Vanguard Series: AMR diagnostics in light of evolving technologies and access in low- and middle-income countries.
    J Antimicrob Chemother. 2021;77:3-4.
    PubMed     Abstract available


  79. FISCHER N, Maex M, Mattheus W, Van den Bossche A, et al
    Genomic epidemiology of persistently circulating MDR Shigella sonnei strains associated with men who have sex with men (MSM) in Belgium (2013-19).
    J Antimicrob Chemother. 2021;77:89-97.
    PubMed     Abstract available


  80. TIMMERMANS M, Bogaerts B, Vanneste K, De Keersmaecker SCJ, et al
    Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.
    J Antimicrob Chemother. 2021;77:49-57.
    PubMed     Abstract available


  81. HUANG SW, Shen MC, Wang WH, Li WY, et al
    High prevalence of HIV-1 transmitted drug resistance and factors associated with time to virological failure and viral suppression in Taiwan.
    J Antimicrob Chemother. 2021;77:185-195.
    PubMed     Abstract available


  82. YOON EJ, Kim HS, Woo H, Choi YJ, et al
    Trajectory of genetic alterations associated with colistin resistance in Acinetobacter baumannii during an in-hospital outbreak of infection.
    J Antimicrob Chemother. 2021;77:69-73.
    PubMed     Abstract available


  83. CAMERON-MCDERMOTT SM, Barrow GJ, Webster AM, De La Haye CO, et al
    Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and syndromic treatment of men with urethral discharge in Kingston, Jamaica, 2018-19.
    J Antimicrob Chemother. 2021;77:218-222.
    PubMed     Abstract available


  84. NURJADI D, Klein S, Hannesen J, Heeg K, et al
    Molecular analysis of an increase in trimethoprim/sulfamethoxazole-resistant MRSA reveals multiple introductions into a tertiary care hospital, Germany 2012-19.
    J Antimicrob Chemother. 2021;77:38-48.
    PubMed     Abstract available


  85. HOWARD-ANDERSON J, Davis M, Page AM, Bower CW, et al
    Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study.
    J Antimicrob Chemother. 2021 Dec 16. pii: 6464149. doi: 10.1093.
    PubMed     Abstract available


  86. TELLO M, Oporto B, Lavin JL, Ocejo M, et al
    Characterization of a carbapenem-resistant Escherichia coli from dairy cattle harbouring blaNDM-1 in an IncC plasmid.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6462046. doi: 10.1093.
    PubMed    


  87. CINTHI M, Coccitto SN, Fioriti S, Morroni G, et al
    Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy.
    J Antimicrob Chemother. 2021 Dec 15. pii: 6463073. doi: 10.1093.
    PubMed     Abstract available


  88. LIU G, Thomsen LE, Olsen JE
    Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459601. doi: 10.1093.
    PubMed     Abstract available


  89. PIRES J, Huisman JS, Bonhoeffer S, Van Boeckel TP, et al
    Increase in antimicrobial resistance in Escherichia coli in food animals between 1980 and 2018 assessed using genomes from public databases.
    J Antimicrob Chemother. 2021 Dec 11. pii: 6459599. doi: 10.1093.
    PubMed     Abstract available


  90. CEBALLOS-GARZON A, Monteoliva L, Gil C, Alvarez-Moreno C, et al
    Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
    J Antimicrob Chemother. 2021 Dec 10. pii: 6459103. doi: 10.1093.
    PubMed     Abstract available


  91. DIAZ-DIAZ S, Recacha E, Garcia-Duque A, Docobo-Perez F, et al
    Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.
    J Antimicrob Chemother. 2021 Dec 8. pii: 6456190. doi: 10.1093.
    PubMed     Abstract available


  92. SUN S, Wang Q, Jin L, Guo Y, et al
    Identification of multiple transfer units and novel subtypes of tmexCD-toprJ gene clusters in clinical carbapenem-resistant Enterobacter cloacae and Klebsiella oxytoca.
    J Antimicrob Chemother. 2021 Dec 7. pii: 6454463. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  93. VOSS A
    BSAC Vanguard Series: The future of infection prevention and control: how COVID is already transforming our approach to antimicrobial resistance.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440021. doi: 10.1093.
    PubMed     Abstract available


  94. DAVIES DS
    BSAC Vanguard Series: Are we finally finding our voice on antimicrobial resistance?
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440039. doi: 10.1093.
    PubMed     Abstract available


  95. HAYWARD G, Turner P
    BSAC Vanguard Series: Antimicrobial resistance and the future of diagnostic testing.
    J Antimicrob Chemother. 2021 Nov 25. pii: 6440024. doi: 10.1093.
    PubMed     Abstract available


  96. COCCITTO SN, Cinthi M, Fioriti S, Morroni G, et al
    Linezolid-resistant Enterococcus gallinarum isolate of swine origin carrying cfr, optrA and poxtA genes.
    J Antimicrob Chemother. 2021 Nov 23. pii: 6433473. doi: 10.1093.
    PubMed     Abstract available


  97. BOUZA E
    The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  98. LAIRD TJ, Jordan D, Lee ZZ, O'Dea M, et al
    Diversity detected in commensals at host and farm level reveals implications for national antimicrobial resistance surveillance programmes.
    J Antimicrob Chemother. 2021 Nov 13. pii: 6427458. doi: 10.1093.
    PubMed     Abstract available


  99. MONTEJANO R, Dominguez-Dominguez L, de Miguel R, Rial-Crestelo D, et al
    Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
    J Antimicrob Chemother. 2021;76:3263-3271.
    PubMed     Abstract available


  100. EGAN SA, Kavanagh NL, Shore AC, Mollerup S, et al
    Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423109. doi: 10.1093.
    PubMed     Abstract available


  101. DELORY T, Le Bel J, Lariven S, Peiffer-Smadja N, et al
    Computerized decision support system (CDSS) use for surveillance of antimicrobial resistance in urinary tract infections in primary care.
    J Antimicrob Chemother. 2021 Nov 8. pii: 6423107. doi: 10.1093.
    PubMed     Abstract available


  102. LIEPA R, Mann R, Osman M, Hamze M, et al
    Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain.
    J Antimicrob Chemother. 2021 Nov 6. pii: 6422573. doi: 10.1093.
    PubMed     Abstract available


  103. TANG N, Hu J, Zhao Y, Song Y, et al
    In vivo evolution of carbapenem resistance in hypervirulent Klebsiella pneumoniae in a patient undergoing long-term treatment.
    J Antimicrob Chemother. 2021 Nov 2. pii: 6415960. doi: 10.1093.
    PubMed    


    October 2021
  104. PRATAMA R, Beukers AG, McIver CJ, Keighley CL, et al
    A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
    J Antimicrob Chemother. 2021 Oct 29. pii: 6414308. doi: 10.1093.
    PubMed     Abstract available


  105. GUILLOTEAU H, Pradalier C, Roman VL, Bellanger X, et al
    Identification of antibiotics triggering the dissemination of antibiotic resistance genes by SXT/R391 elements using a dedicated high-throughput whole-cell biosensor assay.
    J Antimicrob Chemother. 2021 Oct 21. pii: 6407543. doi: 10.1093.
    PubMed     Abstract available


  106. HUANG Y, Rana AP, Wenzler E, Ozer EA, et al
    Aminoglycoside-resistance gene signatures are predictive of aminoglycoside MICs for carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Oct 20. pii: 6403927. doi: 10.1093.
    PubMed     Abstract available


  107. NDASHIMYE E, Li Y, Reyes PS, Avino M, et al
    High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
    J Antimicrob Chemother. 2021;76:2965-2974.
    PubMed     Abstract available


  108. XIE YN, Zhu FX, Zhong YT, Chen YT, et al
    Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.
    J Antimicrob Chemother. 2021;76:2975-2982.
    PubMed     Abstract available


  109. BORTOLAIA V, Ronco T, Romascu L, Nicorescu I, et al
    Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    J Antimicrob Chemother. 2021;76:3063-3065.
    PubMed    


  110. ADAMSON PC, Lin EY, Ha SM, Klausner JD, et al
    Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance.
    J Antimicrob Chemother. 2021;76:2847-2849.
    PubMed     Abstract available


  111. DE LAZZARI E, Gonzalez-Cordon A, Inciarte A, Ugarte A, et al
    Factors associated with the use and composition of two-drug regimens in a large single-centre HIV cohort.
    J Antimicrob Chemother. 2021;76:2988-2992.
    PubMed     Abstract available


  112. CHARPENTIER C, Storto A, Soulie C, Ferre VM, et al
    Prevalence of genotypic baseline risk factors for cabotegravir + rilpivirine failure among ARV-naive patients.
    J Antimicrob Chemother. 2021;76:2983-2987.
    PubMed     Abstract available


  113. HE YZ, Kuang X, Long TF, Li G, et al
    Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli.
    J Antimicrob Chemother. 2021 Oct 6. pii: 6382243. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  114. BARRAUD O, Guichard E, Chainier D, Postil D, et al
    Integrons, a predictive biomarker for antibiotic resistance in acute sepsis: the IRIS study.
    J Antimicrob Chemother. 2021 Sep 24. pii: 6374797. doi: 10.1093.
    PubMed     Abstract available


  115. ZHANG X, Wang L, Li D, Wang C, et al
    Characterization of the novel plasmid-encoded MBL gene blaAFM-1, integrated into a blaIMP-45-bearing transposon Tn6485e in a carbapenem-resistant Pseudomonas aeruginosa clinical isolate.
    J Antimicrob Chemother. 2021 Sep 17. pii: 6371932. doi: 10.1093.
    PubMed     Abstract available


  116. AMBROSE SJ, Hall RM
    Origin of the dfrA44 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Sep 16. pii: 6371308. doi: 10.1093.
    PubMed    


  117. BANGALEE A, Hans L, Steegen K
    Feasibility and clinical relevance of HIV-1 drug resistance testing in patients with low-level viraemia in South Africa.
    J Antimicrob Chemother. 2021;76:2659-2665.
    PubMed     Abstract available


  118. PALACE SG, Fryling KE, Li Y, Wentworth AJ, et al
    Identification of bile acid and fatty acid species as candidate rapidly bactericidal agents for topical treatment of gonorrhoea.
    J Antimicrob Chemother. 2021;76:2569-2577.
    PubMed     Abstract available


  119. ROYER G, Poirel L, La Combe B, Clermont O, et al
    Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:2736-2737.
    PubMed    


  120. MAMA OM, Aspiroz C, Lozano C, Ruiz-Ripa L, et al
    Penicillin susceptibility among invasive MSSA infections: a multicentre study in 16 Spanish hospitals.
    J Antimicrob Chemother. 2021;76:2519-2527.
    PubMed     Abstract available


  121. GILL CM, Abdelraouf K, Oota M, Nakamura R, et al
    Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
    J Antimicrob Chemother. 2021;76:2615-2621.
    PubMed     Abstract available


  122. ABE R, Oyama F, Akeda Y, Nozaki M, et al
    Hospital-wide outbreaks of carbapenem-resistant Enterobacteriaceae horizontally spread through a clonal plasmid harbouring blaIMP-1 in children's hospitals in Japan.
    J Antimicrob Chemother. 2021 Sep 3. pii: 6363635. doi: 10.1093.
    PubMed    


  123. TOMCZYK S, Taylor A, Brown A, de Kraker MEA, et al
    Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
    J Antimicrob Chemother. 2021 Sep 2. pii: 6362680. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  124. TEDIM AP, Lanza VF, Rodriguez CM, Freitas AR, et al
    Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358700. doi: 10.1093.
    PubMed     Abstract available


  125. COUPRI D, Verneuil N, Hartke A, Liebaut A, et al
    Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358701. doi: 10.1093.
    PubMed     Abstract available


  126. MOUNSEY O, Schubert H, Findlay J, Morley K, et al
    Limited phylogenetic overlap between fluoroquinolone-resistant Escherichia coli isolated on dairy farms and those causing bacteriuria in humans living in the same geographical region.
    J Antimicrob Chemother. 2021 Aug 27. pii: 6358704. doi: 10.1093.
    PubMed     Abstract available


  127. ZHU Y, Yang Q, Schwarz S, Yang W, et al
    Identification of a Streptococcus parasuis isolate co-harbouring the oxazolidinone resistance genes cfr(D) and optrA.
    J Antimicrob Chemother. 2021 Aug 18. pii: 6354200. doi: 10.1093.
    PubMed    


  128. HISCOX JA, Khoo SH, Stewart JP, Owen A, et al
    Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?
    J Antimicrob Chemother. 2021;76:2230-2233.
    PubMed     Abstract available


  129. ROSSETTI B, Fabbiani M, Di Carlo D, Incardona F, et al
    Effectiveness of integrase strand transfer inhibitor-based regimens in HIV-infected treatment-naive individuals: results from a European multi-cohort study.
    J Antimicrob Chemother. 2021;76:2394-2399.
    PubMed     Abstract available


  130. MARTIN C, Gracias S, Charpentier C, Descamps D, et al
    HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir.
    J Antimicrob Chemother. 2021;76:2306-2309.
    PubMed     Abstract available


  131. TAYLOR E, Bal AM, Balakrishnan I, Brown NM, et al
    A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK.
    J Antimicrob Chemother. 2021;76:2428-2436.
    PubMed     Abstract available


  132. MARCELIN AG, Charpentier C, Bellecave P, Abdi B, et al
    Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
    J Antimicrob Chemother. 2021;76:2400-2406.
    PubMed     Abstract available


  133. WATERA C, Ssemwanga D, Namayanja G, Asio J, et al
    HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    J Antimicrob Chemother. 2021;76:2407-2414.
    PubMed     Abstract available


  134. GITMAN MR, Alburquerque B, Chung M, van de Guchte A, et al
    Modified methicillin-resistant Staphylococcus aureus detected in neonatal intensive care patients.
    J Antimicrob Chemother. 2021 Aug 9. pii: 6345863. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  135. WICKRAMAGE I, Spigaglia P, Sun X
    Mechanisms of antibiotic resistance of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327067. doi: 10.1093.
    PubMed     Abstract available


  136. LIU P, Hao Z, Liu M, Niu M, et al
    Genetic mutations in adaptive evolution of growth-independent vancomycin-tolerant Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jul 23. pii: 6327451. doi: 10.1093.
    PubMed     Abstract available


  137. LUCENA NEMIROSKY J, Espelt R, Lopez Grado E, Sobrino J, et al
    Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study.
    J Antimicrob Chemother. 2021 Jul 19. pii: 6323546. doi: 10.1093.
    PubMed     Abstract available


  138. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of plazomicin against carbapenem-intermediate or -resistant Escherichia coli isolates from the United States and international sites in relation to clonal background, resistance genes, co-resistance, and region.
    J Antimicrob Chemother. 2021;76:2061-2070.
    PubMed     Abstract available


  139. MILLIERE L, Bocket L, Tinez C, Robineau O, et al
    Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping.
    J Antimicrob Chemother. 2021;76:2143-2147.
    PubMed     Abstract available


  140. TROTT DJ, Turnidge J, Kovac JH, Simjee S, et al
    Comparative macrolide use in humans and animals: should macrolides be moved off the World Health Organisation's critically important antimicrobial list?
    J Antimicrob Chemother. 2021;76:1955-1961.
    PubMed     Abstract available


  141. BRENNER BG, Oliveira M, Ibanescu RI, Routy JP, et al
    Cell culture selections reveal favourable drug resistance profiles for doravirine and islatravir.
    J Antimicrob Chemother. 2021;76:2137-2142.
    PubMed     Abstract available


  142. BIGGEL M, Zurfluh K, Treier A, Nuesch-Inderbinen M, et al
    Characteristics of fosA-carrying plasmids in E. coli and Klebsiella spp. isolates originating from food and environmental samples.
    J Antimicrob Chemother. 2021;76:2004-2011.
    PubMed     Abstract available


    June 2021
  143. AMBROSE SJ, Hall RM
    dfrA trimethoprim resistance genes found in Gram-negative bacteria: compilation and unambiguous numbering.
    J Antimicrob Chemother. 2021 Jun 28. pii: 6310424. doi: 10.1093.
    PubMed     Abstract available


  144. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed     Abstract available


  145. LU HF, Tsai YC, Li LH, Lin YT, et al
    Role of AzoR, a LysR-type transcriptional regulator, in SmeVWX pump-mediated antibiotic resistance in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307154. doi: 10.1093.
    PubMed     Abstract available


  146. ZINNER SH, Alieva KN, Golikova MV, Strukova EN, et al
    Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.
    J Antimicrob Chemother. 2021;76:1832-1839.
    PubMed     Abstract available


  147. HORNER C, Mushtaq S, Allen M, Longshaw C, et al
    Are resistance rates among bloodstream isolates a good proxy for other infections? Analysis from the BSAC Resistance Surveillance Programme.
    J Antimicrob Chemother. 2021;76:1822-1831.
    PubMed     Abstract available


  148. LAUMEN JGE, Manoharan-Basil SS, Verhoeven E, Abdellati S, et al
    Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2021;76:1752-1758.
    PubMed     Abstract available


  149. DE KORNE-ELENBAAS J, Bruisten SM, de Vries HJC, Van Dam AP, et al
    Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis.
    J Antimicrob Chemother. 2021;76:1759-1768.
    PubMed     Abstract available


  150. JIMENEZ DE ORY S, Beltran-Pavez C, Gutierrez-Lopez M, Santos MDM, et al
    Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure.
    J Antimicrob Chemother. 2021;76:1886-1892.
    PubMed     Abstract available


  151. GISKE CG, Kahlmeter G, MacGowan A, Turnidge J, et al
    Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study.
    J Antimicrob Chemother. 2021;76:1949-1950.
    PubMed    


  152. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Erratum to: Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Jun 14. pii: 6298302. doi: 10.1093.
    PubMed    


    May 2021
  153. BERBEL D, Camara J, Gonzalez-Diaz A, Cubero M, et al
    Deciphering mobile genetic elements disseminating macrolide resistance in Streptococcus pyogenes over a 21 year period in Barcelona, Spain.
    J Antimicrob Chemother. 2021 May 20. pii: 6279207. doi: 10.1093.
    PubMed     Abstract available


  154. ABDI B, Chebbi M, Wirden M, Teyssou E, et al
    No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments.
    J Antimicrob Chemother. 2021;76:1553-1557.
    PubMed     Abstract available


  155. LI JZ, Stella N, Choudhary MC, Javed A, et al
    Impact of pre-existing drug resistance on risk of virological failure in South Africa.
    J Antimicrob Chemother. 2021;76:1558-1563.
    PubMed     Abstract available


  156. MERNISSI T, Bodeau S, Andre C, Zahr N, et al
    An HPLC assay for the therapeutic drug monitoring of cefiderocol in critically ill patients.
    J Antimicrob Chemother. 2021;76:1643-1646.
    PubMed    


  157. YADAV K, Garoff L, Huseby DL, Hughes D, et al
    Phenotypic and genetic barriers to establishment of horizontally transferred genes encoding ribosomal protection proteins.
    J Antimicrob Chemother. 2021;76:1441-1447.
    PubMed     Abstract available


  158. ADAMECZ Z, Nielsen KL, Kirkby NS, Frimodt-Moller N, et al
    Aminoglycoside resistance genes in Enterococcus faecium: mismatch with phenotype.
    J Antimicrob Chemother. 2021 May 9. pii: 6272857. doi: 10.1093.
    PubMed    


  159. WANG W, Sun B
    VraCP regulates cell wall metabolism and antibiotic resistance in vancomycin-intermediate Staphylococcus aureus strain Mu50.
    J Antimicrob Chemother. 2021 May 5. pii: 6264898. doi: 10.1093.
    PubMed     Abstract available


  160. HAO M, Schuyler J, Zhang H, Shashkina E, et al
    Apramycin resistance in epidemic carbapenem-resistant Klebsiella pneumoniae ST258 strains.
    J Antimicrob Chemother. 2021 May 3. pii: 6263424. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  161. PUTSATHIT P, Hong S, George N, Hemphill C, et al
    Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6250920. doi: 10.1093.
    PubMed     Abstract available


  162. DEJOIES L, Sassi M, Schutz S, Moreaux J, et al
    Genetic features of the poxtA linezolid resistance gene in human enterococci from France.
    J Antimicrob Chemother. 2021 Apr 25. pii: 6251856. doi: 10.1093.
    PubMed     Abstract available


  163. TRUSWELL A, Abraham R, O'Dea M, Lee ZZ, et al
    Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance.
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248215. doi: 10.1093.
    PubMed     Abstract available


  164. RAOULT D, Hadjadj L, Baron SA, Rolain JM, et al
    Role of glyphosate in the emergence of antimicrobial resistance in bacteria?
    J Antimicrob Chemother. 2021 Apr 24. pii: 6248211. doi: 10.1093.
    PubMed     Abstract available


  165. BOEKHOUD IM, Sidorov I, Nooij S, Harmanus C, et al
    Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile.
    J Antimicrob Chemother. 2021 Apr 20. pii: 6239454. doi: 10.1093.
    PubMed     Abstract available


  166. AMBROSE SJ, Hall RM
    Identification of the dfrA4 trimethoprim resistance gene.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226985. doi: 10.1093.
    PubMed    


  167. NI W, Yang D, Guan J, Xi W, et al
    In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021 Apr 16. pii: 6226986. doi: 10.1093.
    PubMed     Abstract available


  168. WALKER SV, Wolke M, Plum G, Weber RE, et al
    Failure of Vitek2 to reliably detect vanB-mediated vancomycin resistance in Enterococcus faecium.
    J Antimicrob Chemother. 2021 Apr 14. pii: 6225960. doi: 10.1093.
    PubMed     Abstract available


  169. DELAUGERRE C, Nere ML, Eymard-Duvernay S, Armero A, et al
    Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
    J Antimicrob Chemother. 2021;76:1286-1293.
    PubMed     Abstract available


  170. BROWN JA, Amstutz A, Nsakala BL, Seeburg U, et al
    Extensive drug resistance during low-level HIV viraemia while taking NNRTI-based ART supports lowering the viral load threshold for regimen switch in resource-limited settings: a pre-planned analysis from the SESOTHO trial.
    J Antimicrob Chemother. 2021;76:1294-1298.
    PubMed     Abstract available


  171. UNEMO M, Ahlstrand J, Sanchez-Buso L, Day M, et al
    High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
    J Antimicrob Chemother. 2021;76:1221-1228.
    PubMed     Abstract available


  172. NOBREGA D, Peirano G, Lynch T, Finn TJ, et al
    Spatial distribution of Escherichia coli ST131 C subclades in a centralized Canadian urban region.
    J Antimicrob Chemother. 2021;76:1135-1139.
    PubMed     Abstract available


  173. FELICIO MR, Silveira GGOS, Oshiro KGN, Meneguetti BT, et al
    Polyalanine peptide variations may have different mechanisms of action against multidrug-resistant bacterial pathogens.
    J Antimicrob Chemother. 2021;76:1174-1186.
    PubMed     Abstract available


  174. SEMENGUE ENJ, Armenia D, Inzaule S, Santoro MM, et al
    Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    J Antimicrob Chemother. 2021;76:1277-1285.
    PubMed     Abstract available


  175. FIFER H, Livermore DM, Uthayakumaran T, Woodford N, et al
    What's left in the cupboard? Older antimicrobials for treating gonorrhoea.
    J Antimicrob Chemother. 2021;76:1215-1220.
    PubMed     Abstract available


  176. MASHE T, Leekitcharoenphon P, Mtapuri-Zinyowera S, Kingsley RA, et al
    Salmonella enterica serovar Typhi H58 clone has been endemic in Zimbabwe from 2012 to 2019.
    J Antimicrob Chemother. 2021;76:1160-1167.
    PubMed     Abstract available


  177. CASTANEDA X, Garcia-De-la-Maria C, Gasch O, Pericas JM, et al
    Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocardit
    J Antimicrob Chemother. 2021 Apr 9. pii: 6219388. doi: 10.1093.
    PubMed     Abstract available


  178. LEANGAPICHART T, Lunha K, Jiwakanon J, Angkititrakul S, et al
    Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes.
    J Antimicrob Chemother. 2021 Apr 8. pii: 6215053. doi: 10.1093.
    PubMed     Abstract available


  179. JIANG N, Wyres KL, Li J, Fessler AT, et al
    Evolution and genomic insight into methicillin-resistant Staphylococcus aureus ST9 in China.
    J Antimicrob Chemother. 2021 Apr 5. pii: 6210593. doi: 10.1093.
    PubMed     Abstract available


  180. CHEN YH, Lin SY, Lin YT, Tseng SP, et al
    Emergence of aac(6')-Ie-aph(2'')-Ia-positive enterococci with non-high-level gentamicin resistance mediated by IS1216V: adaptation to decreased aminoglycoside usage in Taiwan.
    J Antimicrob Chemother. 2021 Apr 2. pii: 6208785. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  181. ALVAREZ-MARIN R, Lopez-Cerero L, Guerrero-Sanchez F, Palop-Borras B, et al
    Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
    J Antimicrob Chemother. 2021 Mar 26. pii: 6189039. doi: 10.1093.
    PubMed     Abstract available


  182. LUCASSEN K, Muller C, Wille J, Xanthopoulou K, et al
    Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184842. doi: 10.1093.
    PubMed     Abstract available


  183. MUSHTAQ S, Garello P, Vickers A, Woodford N, et al
    Activity of cefepime/zidebactam (WCK 5222) against 'problem' antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184840. doi: 10.1093.
    PubMed     Abstract available


  184. LI R, Peng K, Xiao X, Liu Y, et al
    Emergence of a multidrug resistance efflux pump with carbapenem resistance gene blaVIM-2 in a Pseudomonas putida megaplasmid of migratory bird origin.
    J Antimicrob Chemother. 2021 Mar 24. pii: 6184583. doi: 10.1093.
    PubMed     Abstract available


  185. HUANG HH, Wu BK, Li LH, Lin YT, et al
    Role of the PhoPQ two-component regulatory system in the beta-lactam resistance of Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Mar 19. pii: 6178648. doi: 10.1093.
    PubMed     Abstract available


  186. KRAGH KN, Gijon D, Maruri A, Antonelli A, et al
    Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.
    J Antimicrob Chemother. 2021;76:1001-1009.
    PubMed     Abstract available


  187. YAN J, Chen Y, Yang F, Ling X, et al
    High percentage of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone among isolates from a single hospital in Hangzhou, China.
    J Antimicrob Chemother. 2021;76:936-939.
    PubMed     Abstract available


  188. SALMERON P, Moreno-Mingorance A, Trejo J, Amado R, et al
    Emergence and dissemination of three mild outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-18.
    J Antimicrob Chemother. 2021;76:930-935.
    PubMed     Abstract available


  189. ENGONE-ONDO JD, Mouinga-Ondeme A, Lekana-Douki SE, Diane A, et al
    High rate of virological failure and HIV drug resistance in semi-rural Gabon and implications for dolutegravir-based regimen efficacy.
    J Antimicrob Chemother. 2021;76:1051-1056.
    PubMed     Abstract available


  190. JONES JC, Pascua PNQ, Harrington WN, Webby RJ, et al
    Multiple polymerase acidic (PA) I38X substitutions in influenza A(H1N1)pdm09 virus permit polymerase activity and cause reduced baloxavir inhibition.
    J Antimicrob Chemother. 2021;76:957-960.
    PubMed     Abstract available


  191. CABOT G, Lara-Esbri P, Mulet X, Oliver A, et al
    Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
    J Antimicrob Chemother. 2021;76:945-949.
    PubMed     Abstract available


    February 2021
  192. FERNANDEZ-HUERTA M, Serra-Pladevall J, Pumarola T, Pich OQ, et al
    Comment on: Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2021 Feb 28. pii: 6154381. doi: 10.1093.
    PubMed    


  193. PORTAL E, Descours G, Ginevra C, Mentasti M, et al
    Legionella antibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?
    J Antimicrob Chemother. 2021 Feb 20. pii: 6145330. doi: 10.1093.
    PubMed     Abstract available


  194. BROWN NM, Brown EM
    Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK.
    J Antimicrob Chemother. 2021 Feb 14. pii: 6134889. doi: 10.1093.
    PubMed     Abstract available


  195. SALMERON P, Vinado B, Arando M, Alcoceba E, et al
    Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
    J Antimicrob Chemother. 2021 Feb 11. pii: 6132746. doi: 10.1093.
    PubMed     Abstract available


  196. GUO S, Aung KT, Leekitcharoenphon P, Tay MYF, et al
    Prevalence and genomic analysis of ESBL-producing Escherichia coli in retail raw meats in Singapore.
    J Antimicrob Chemother. 2021;76:601-605.
    PubMed     Abstract available


  197. KAO SW, Liu ZH, Wu TS, Ku SW, et al
    Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.
    J Antimicrob Chemother. 2021;76:722-728.
    PubMed     Abstract available


  198. BUTLER DA, Rana AP, Krapp F, Patel SR, et al
    Optimizing aminoglycoside selection for KPC-producing Klebsiella pneumoniae with the aminoglycoside-modifying enzyme (AME) gene aac(6')-Ib.
    J Antimicrob Chemother. 2021;76:671-679.
    PubMed     Abstract available


  199. YAO H, Zhao W, Jiao D, Schwarz S, et al
    Global distribution, dissemination and overexpression of potent multidrug efflux pump RE-CmeABC in Campylobacter jejuni.
    J Antimicrob Chemother. 2021;76:596-600.
    PubMed     Abstract available


  200. PHAM HT, Alves BM, Yoo S, Xiao MA, et al
    Progressive emergence of an S153F plus R263K combination of integrase mutations in the proviral DNA of one individual successfully treated with dolutegravir.
    J Antimicrob Chemother. 2021;76:639-647.
    PubMed     Abstract available


  201. TAKEBAYASHI Y, Findlay J, Heesom KJ, Warburton PJ, et al
    Variability in carbapenemase activity of intrinsic OxaAb (OXA-51-like) beta-lactamase enzymes in Acinetobacter baumannii.
    J Antimicrob Chemother. 2021;76:587-595.
    PubMed     Abstract available


  202. LE ROY C, Touati A, Balcon C, Garraud J, et al
    Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and Chlamydia trachomatis.
    J Antimicrob Chemother. 2021 Feb 4. pii: 6127604. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  203. TEMKIN E, Margalit I, Nutman A, Carmeli Y, et al
    Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects.
    J Antimicrob Chemother. 2021;76.
    PubMed     Abstract available


  204. LIU H, Moran RA, Chen Y, Doughty EL, et al
    Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids.
    J Antimicrob Chemother. 2021 Jan 27. pii: 6121227. doi: 10.1093.
    PubMed     Abstract available


  205. AULIN LBS, Koumans CIM, Haakman Y, van Os W, et al
    Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2021;76:533-535.
    PubMed    


  206. MACHUCA J, Recacha E, Gallego-Mesa B, Diaz-Diaz S, et al
    Effect of RecA inactivation on quinolone susceptibility and the evolution of resistance in clinical isolates of Escherichia coli.
    J Antimicrob Chemother. 2021;76:338-344.
    PubMed     Abstract available


  207. HERNANDEZ-GARCIA M, Garcia-Castillo M, Garcia-Fernandez S, Melo-Cristino J, et al
    Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
    J Antimicrob Chemother. 2021;76:370-379.
    PubMed     Abstract available


  208. AIHARA M, Nishida R, Akimoto M, Gotoh Y, et al
    Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance.
    J Antimicrob Chemother. 2021;76:362-369.
    PubMed     Abstract available


  209. HAMIDIAN M, Ambrose SJ, Blackwell GA, Nigro SJ, et al
    An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8 Acinetobacter baumannii isolates at a Sydney hospital.
    J Antimicrob Chemother. 2021 Jan 16. pii: 6102239. doi: 10.1093.
    PubMed     Abstract available


  210. SWEENEY EL, Lowry K, Bletchly C, Nimmo GR, et al
    Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains.
    J Antimicrob Chemother. 2021 Jan 15. pii: 6100778. doi: 10.1093.
    PubMed     Abstract available


  211. GOLPARIAN D, Sanchez-Buso L, Cole M, Unemo M, et al
    Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions.
    J Antimicrob Chemother. 2021 Jan 7. pii: 6067623. doi: 10.1093.
    PubMed     Abstract available


  212. MUSHTAQ S, Vickers A, Doumith M, Ellington MJ, et al
    Activity of beta-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria.
    J Antimicrob Chemother. 2021;76:160-170.
    PubMed     Abstract available


  213. MARTIN E, Philbin M, Hughes G, Bergin C, et al
    Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic.
    J Antimicrob Chemother. 2021;76:272-275.
    PubMed    


  214. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed     Abstract available


  215. HUA X, Moran RA, Xu Q, He J, et al
    Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2021;76:65-69.
    PubMed     Abstract available


  216. CHERNY SS, Nevo D, Baraz A, Baruch S, et al
    Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling.
    J Antimicrob Chemother. 2021;76:239-248.
    PubMed     Abstract available


  217. SALADINI F, Giammarino F, Hosseini BA, Giannini A, et al
    In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
    J Antimicrob Chemother. 2021;76:130-134.
    PubMed     Abstract available


  218. WENK BM, Mbunkah HA, Nsanwe NN, Mbu ET, et al
    Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
    J Antimicrob Chemother. 2021;76:124-129.
    PubMed     Abstract available


    December 2020
  219. XANTHOPOULOU K, Wille J, Zweigner J, Lucassen K, et al
    Characterization of a vancomycin-resistant Enterococcus faecium isolate and a vancomycin-susceptible E. faecium isolate from the same blood culture.
    J Antimicrob Chemother. 2020 Dec 28. pii: 6054276. doi: 10.1093.
    PubMed     Abstract available


  220. BLACKMAN A, Morrison B, Maruri F, van der Heijden Y, et al
    Re-evaluation of a novel resistance mutation in eccC5 of the ESX-5 secretion system in ofloxacin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 2020 Dec 23. pii: 6046147. doi: 10.1093.
    PubMed    


  221. PEZZANI MD, Mazzaferri F, Compri M, Galia L, et al
    Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  222. MIRANDA C, Silva V, Capita R, Alonso-Calleja C, et al
    Implications of antibiotics use during the COVID-19 pandemic: present and future.
    J Antimicrob Chemother. 2020;75:3413-3416.
    PubMed     Abstract available


    November 2020
  223. ZHU Y, Wang C, Schwarz S, Liu W, et al
    Identification of a novel tetracycline resistance gene, tet(63), located on a multiresistance plasmid from Staphylococcus aureus.
    J Antimicrob Chemother. 2020 Nov 28. pii: 6008797. doi: 10.1093.
    PubMed     Abstract available


  224. YUSEF D, Hayajneh WA, Bani Issa A, Haddad R, et al
    Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in Jordan.
    J Antimicrob Chemother. 2020 Nov 21. pii: 5997451. doi: 10.1093.
    PubMed     Abstract available


  225. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Ilkit M, et al
    Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?
    J Antimicrob Chemother. 2020 Nov 11. pii: 5974114. doi: 10.1093.
    PubMed     Abstract available


  226. SHROPSHIRE WC, Aitken SL, Pifer R, Kim J, et al
    IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort.
    J Antimicrob Chemother. 2020 Nov 9. pii: 5961599. doi: 10.1093.
    PubMed     Abstract available


  227. MAGALLON A, Roussel M, Neuwirth C, Tetu J, et al
    Fluoroquinolone resistance in Achromobacter spp.: substitutions in QRDRs of GyrA, GyrB, ParC and ParE and implication of the RND efflux system AxyEF-OprN.
    J Antimicrob Chemother. 2020 Nov 6. pii: 5959825. doi: 10.1093.
    PubMed     Abstract available


  228. OOI N, Lee VE, Chalam-Judge N, Newman R, et al
    Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-beta-lactamases in carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957246. doi: 10.1093.
    PubMed     Abstract available


  229. HAYAJNEH WA, Al-Azzam S, Yusef D, Lattyak WJ, et al
    Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
    J Antimicrob Chemother. 2020 Nov 5. pii: 5957247. doi: 10.1093.
    PubMed     Abstract available


  230. NOBREGA DB, Tang KL, Caffrey NP, De Buck J, et al
    Prevalence of antimicrobial resistance genes and its association with restricted antimicrobial use in food-producing animals: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2020 Nov 4. pii: 5955902. doi: 10.1093.
    PubMed     Abstract available


  231. COMBER SDW, Upton M, Lewin S, Powell N, et al
    COVID-19, antibiotics and One Health: a UK environmental risk assessment.
    J Antimicrob Chemother. 2020;75:3411-3412.
    PubMed    


    October 2020
  232. TKADLEC J, Capek V, Brajerova M, Smelikova E, et al
    The molecular epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in the Czech Republic.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942696. doi: 10.1093.
    PubMed     Abstract available


  233. FERNANDEZ JE, Perreten V, Schwendener S
    The novel macrolide resistance genes mef(F) and msr(G) are located on a plasmid in Macrococcus canis and a transposon in Macrococcus caseolyticus.
    J Antimicrob Chemother. 2020 Oct 29. pii: 5942709. doi: 10.1093.
    PubMed     Abstract available


  234. GUIRAUD J, Lounnas M, Boissiere A, Le Roy C, et al
    Lower mgpB diversity in macrolide-resistant Mycoplasma genitalium infecting men visiting two sexually transmitted infection clinics in Montpellier, France.
    J Antimicrob Chemother. 2020 Oct 20. pii: 5930856. doi: 10.1093.
    PubMed     Abstract available


  235. LEGER A, Lambraki I, Graells T, Cousins M, et al
    AMR-Intervene: a social-ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective.
    J Antimicrob Chemother. 2020 Oct 14. pii: 5923757. doi: 10.1093.
    PubMed     Abstract available


  236. ARA-MONTOJO MF, Escosa-Garcia L, Alguacil-Guillen M, Seara N, et al
    Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
    J Antimicrob Chemother. 2020 Oct 10. pii: 5920733. doi: 10.1093.
    PubMed     Abstract available


  237. JOHANSSON MHK, Bortolaia V, Tansirichaiya S, Aarestrup FM, et al
    Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder.
    J Antimicrob Chemother. 2020 Oct 3. pii: 5917579. doi: 10.1093.
    PubMed     Abstract available


  238. HOBSON CA, Cointe A, Bidet P, Poupon J, et al
    Urine zinc concentrations allow proper expression of metallo-beta-lactamases in Enterobacteriaceae.
    J Antimicrob Chemother. 2020;75:3077-3079.
    PubMed    


  239. PAPATHANAKOS G, Andrianopoulos I, Papathanasiou A, Koulenti D, et al
    Pandrug-resistant Acinetobacter baumannii treatment: still a debatable topic with no definite solutions.
    J Antimicrob Chemother. 2020;75:3081.
    PubMed    


    September 2020
  240. HADAD R, Cole MJ, Ebeyan S, Jacobsson S, et al
    Evaluation of the SpeeDx ResistancePlus(R) GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905664. doi: 10.1093.
    PubMed     Abstract available


  241. ROUX J, Nekkab N, Colomb-Cotinat M, Astagneau P, et al
    Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905635. doi: 10.1093.
    PubMed     Abstract available


  242. AMBROSE SJ, Hall RM
    A novel trimethoprim resistance gene, dfrA38, found in a sporadic Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2020 Sep 15. pii: 5905668. doi: 10.1093.
    PubMed    


  243. TREBOSC V, Schellhorn B, Schill J, Lucchini V, et al
    In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms.
    J Antimicrob Chemother. 2020 Sep 1. pii: 5899886. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  244. LIAO CH, Chen WC, Li LH, Lin YT, et al
    AmpR of Stenotrophomonas maltophilia is involved in stenobactin synthesis and enhanced beta-lactam resistance in an iron-depleted condition.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899264. doi: 10.1093.
    PubMed     Abstract available


  245. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed     Abstract available


  246. DIACONU EL, Carfora V, Alba P, Di Matteo P, et al
    Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    J Antimicrob Chemother. 2020 Aug 24. pii: 5896583. doi: 10.1093.
    PubMed     Abstract available


  247. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed     Abstract available


  248. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed     Abstract available


  249. LYU T, Cheung KS, Ni L, Guo J, et al
    High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891805. doi: 10.1093.
    PubMed     Abstract available


  250. GOLPARIAN D, Bazzo ML, Golfetto L, Gaspar PC, et al
    Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16.
    J Antimicrob Chemother. 2020 Aug 12. pii: 5891806. doi: 10.1093.
    PubMed     Abstract available


    July 2020
  251. DAI VTT, Beissbarth J, Thanh PV, Hoan PT, et al
    Hospital surveillance predicts community pneumococcal antibiotic resistance in Vietnam.
    J Antimicrob Chemother. 2020 Jul 29. pii: 5878176. doi: 10.1093.
    PubMed     Abstract available


  252. RODRIGUEZ-RUBIO L, Serna C, Ares-Arroyo M, Matamoros BR, et al
    Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages.
    J Antimicrob Chemother. 2020 Jul 28. pii: 5876565. doi: 10.1093.
    PubMed     Abstract available


  253. XANTHOPOULOU K, Peter S, Tobys D, Behnke M, et al
    Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology.
    J Antimicrob Chemother. 2020 Jul 22. pii: 5875232. doi: 10.1093.
    PubMed     Abstract available


  254. LI Y, Xiu L, Liu J, Zhang C, et al
    A multiplex assay for characterization of antimicrobial resistance in Neisseria gonorrhoeae using multi-PCR coupled with mass spectrometry.
    J Antimicrob Chemother. 2020 Jul 20. pii: 5874078. doi: 10.1093.
    PubMed     Abstract available


  255. CHAN AP, Choi Y, Clarke TH, Brinkac LM, et al
    AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates.
    J Antimicrob Chemother. 2020 Jul 18. pii: 5873331. doi: 10.1093.
    PubMed     Abstract available


  256. ZHANG S, Wang X, Wise MJ, He Y, et al
    Mutations of Helicobacter pylori RdxA are mainly related to the phylogenetic origin of the strain and not to metronidazole resistance.
    J Antimicrob Chemother. 2020 Jul 17. pii: 5872801. doi: 10.1093.
    PubMed     Abstract available


  257. MAHFOUZ N, Ferreira I, Beisken S, von Haeseler A, et al
    Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review.
    J Antimicrob Chemother. 2020 Jul 13. pii: 5870983. doi: 10.1093.
    PubMed     Abstract available


  258. RIVAYA B, Jordana-Lluch E, Fernandez-Rivas G, Molinos S, et al
    Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain.
    J Antimicrob Chemother. 2020 Jul 12. pii: 5870410. doi: 10.1093.
    PubMed     Abstract available


  259. CAO T, Liu Y, Li Y, Wang Y, et al
    A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment.
    J Antimicrob Chemother. 2020 Jul 4. pii: 5867249. doi: 10.1093.
    PubMed     Abstract available


  260. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  261. SATO T, Wada T, Shinagawa M, Fukushima Y, et al
    Emergence of vancomycin- and teicoplanin-resistant Enterococcus faecium via vanD5-harbouring large genomic island.
    J Antimicrob Chemother. 2020 Jun 25. pii: 5862743. doi: 10.1093.
    PubMed     Abstract available


  262. SEIFERT H, Muller C, Stefanik D, Higgins PG, et al
    In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855123. doi: 10.1093.
    PubMed     Abstract available


  263. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  264. SAVOLDI A, Carrara E, Tacconelli E
    Gross national income and antibiotic resistance in invasive isolates: analysis of the top-ranked antibiotic-resistant bacteria on the 2017 WHO priority list-authors' response.
    J Antimicrob Chemother. 2020 May 27. pii: 5847827. doi: 10.1093.
    PubMed    


  265. LAM TT, Nurnberg S, Claus H, Vogel U, et al
    Molecular epidemiology of imipenem resistance in invasive Haemophilus influenzae infections in Germany in 2016.
    J Antimicrob Chemother. 2020 May 25. pii: 5843865. doi: 10.1093.
    PubMed     Abstract available


  266. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed     Abstract available


  267. MUGGEO A, Cambau E, Amara M, Micaelo M, et al
    Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance.
    J Antimicrob Chemother. 2020 May 22. pii: 5842234. doi: 10.1093.
    PubMed     Abstract available


  268. RAWSON TM, Moore LSP, Castro-Sanchez E, Charani E, et al
    COVID-19 and the potential long-term impact on antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 20. pii: 5841159. doi: 10.1093.
    PubMed     Abstract available


  269. ORTIZ-PADILLA M, Diaz-Diaz S, Machuca J, Tejada-Gonzalez A, et al
    Role of low-level quinolone resistance in generating tolerance in Escherichia coli under therapeutic concentrations of ciprofloxacin.
    J Antimicrob Chemother. 2020 May 19. pii: 5836071. doi: 10.1093.
    PubMed     Abstract available


  270. DE LASTOURS V, Laouenan C, Royer G, Carbonnelle E, et al
    Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
    J Antimicrob Chemother. 2020 May 17. pii: 5838343. doi: 10.1093.
    PubMed     Abstract available


  271. MARTINEZ EP, van Rosmalen J, Bustillos R, Natsch S, et al
    Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands.
    J Antimicrob Chemother. 2020 May 17. pii: 5838345. doi: 10.1093.
    PubMed     Abstract available


  272. EICHEL V, Klein S, Bootsveld C, Frank U, et al
    Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
    J Antimicrob Chemother. 2020 May 15. pii: 5837672. doi: 10.1093.
    PubMed     Abstract available


  273. VAN GAALEN RD, Altorf-van der Kuil W, Wegdam-Blans MCA, Aguilar Diaz JM, et al
    Determination of the time-dependent association between ciprofloxacin consumption and ciprofloxacin resistance using a weighted cumulative exposure model compared with standard models.
    J Antimicrob Chemother. 2020 May 14. pii: 5837067. doi: 10.1093.
    PubMed     Abstract available


  274. LI LH, Wu CM, Lin YT, Pan SY, et al
    Roles of FadRACB system in formaldehyde detoxification, oxidative stress alleviation and antibiotic susceptibility in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2020 May 14. pii: 5837066. doi: 10.1093.
    PubMed     Abstract available


  275. CHANAME PINEDO LE, Bruyndonckx R, Catry B, Latour K, et al
    Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case-control study.
    J Antimicrob Chemother. 2020 May 12. pii: 5836063. doi: 10.1093.
    PubMed     Abstract available


  276. MANOHARAN A, Das T, Whiteley GS, Glasbey T, et al
    The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2020 May 3. pii: 5828489. doi: 10.1093.
    PubMed     Abstract available


  277. DELORY T, Jeanmougin P, Lariven S, Aubert JP, et al
    A computerized decision support system (CDSS) for antibiotic prescription in primary care-Antibioclic: implementation, adoption and sustainable use in the era of extended antimicrobial resistance.
    J Antimicrob Chemother. 2020 May 1. pii: 5827803. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  278. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed     Abstract available


  279. TORUMKUNEY D, Tunger A, Sancak B, Bicakcigil A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  280. TORUMKUNEY D, Van PH, Thinh LQ, Koo SH, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-18 in Vietnam, Cambodia, Singapore and the Philippines: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  281. TORUMKUNEY D, Bratus E, Yuvko O, Pertseva T, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2016-17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  282. TORUMKUNEY D, Hammami A, Mezghani Maalej S, Ayed NB, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-18 in Tunisia, Kenya and Morocco: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  283. TORUMKUNEY D, Anwar S, Nizamuddin S, Malik N, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  284. TORUMKUNEY D, Smayevsky J, Relloso MS, Sucari A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


  285. TORUMKUNEY D, Mokaddas E, Jiman-Fatani A, Ageel A, et al
    Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
    J Antimicrob Chemother. 2020;75.
    PubMed     Abstract available


    March 2020
  286. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  287. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed     Abstract available


  288. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  289. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed    


  290. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed     Abstract available


  291. LIM JM, Singh SR, Duong MC, Legido-Quigley H, et al
    Impact of national interventions to promote responsible antibiotic use: a systematic review.
    J Antimicrob Chemother. 2020;75:14-29.
    PubMed     Abstract available


  292. VISSEAUX B, Assoumou L, Mahjoub N, Grude M, et al
    Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?
    J Antimicrob Chemother. 2020;75:183-193.
    PubMed     Abstract available


  293. KIDD JM, Abdelraouf K, Nicolau DP
    Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model.
    J Antimicrob Chemother. 2020;75:149-155.
    PubMed     Abstract available


  294. PAUL D, Babenko D, Toleman MA
    Human carriage of cefotaxime-resistant Escherichia coli in North-East India: an analysis of STs and associated resistance mechanisms.
    J Antimicrob Chemother. 2020;75:72-76.
    PubMed     Abstract available


  295. TZOU PL, Rhee SY, Descamps D, Clutter DS, et al
    Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    J Antimicrob Chemother. 2020;75:170-182.
    PubMed     Abstract available


  296. WAREHAM DW, Momin MHFA, Phee LM, Hornsey M, et al
    Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
    J Antimicrob Chemother. 2020;75:135-139.
    PubMed     Abstract available


  297. RODRIGUEZ-VILLODRES A, Gil-Marques ML, Alvarez-Marin R, Bonnin RA, et al
    Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.
    J Antimicrob Chemother. 2020;75:77-85.
    PubMed     Abstract available


  298. MODICA S, Redi D, Gagliardini R, Giombini E, et al
    Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study.
    J Antimicrob Chemother. 2020;75:194-199.
    PubMed     Abstract available


  299. LUO Q, Wan F, Yu X, Zheng B, et al
    MDR Salmonella enterica serovar Typhimurium ST34 carrying mcr-1 isolated from cases of bloodstream and intestinal infection in children in China.
    J Antimicrob Chemother. 2020;75:92-95.
    PubMed     Abstract available


  300. DORTET L, Broda A, Bernabeu S, Glupczynski Y, et al
    Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
    J Antimicrob Chemother. 2020;75:110-116.
    PubMed     Abstract available


  301. MARTINS-SORENSON N, Snesrud E, Xavier DE, Cacci LC, et al
    A novel plasmid-encoded mcr-4.3 gene in a colistin-resistant Acinetobacter baumannii clinical strain.
    J Antimicrob Chemother. 2020;75:60-64.
    PubMed     Abstract available


  302. FINDLAY J, Gould VC, North P, Bowker KE, et al
    Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017-18.
    J Antimicrob Chemother. 2020;75:65-71.
    PubMed     Abstract available


    December 2019
  303. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed     Abstract available


  304. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  305. VAN DER LINDEN M, Mamede R, Levina N, Helwig P, et al
    Heterogeneity of penicillin-non-susceptible group B streptococci isolated from a single patient in Germany.
    J Antimicrob Chemother. 2019 Nov 18. pii: 5628284. doi: 10.1093.
    PubMed     Abstract available


  306. LI D, Cheng Y, Schwarz S, Yang M, et al
    Identification of a poxtA- and cfr-carrying multiresistant Enterococcus hirae strain.
    J Antimicrob Chemother. 2019 Nov 6. pii: 5613772. doi: 10.1093.
    PubMed    


    October 2019
  307. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
    J Antimicrob Chemother. 2019 Oct 29. pii: 5609145. doi: 10.1093.
    PubMed     Abstract available


  308. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed    


  309. BIRGY A, Madhi F, Jung C, Levy C, et al
    Diversity and trends in population structure of ESBL-producing Enterobacteriaceae in febrile urinary tract infections in children in France from 2014 to 2017.
    J Antimicrob Chemother. 2019 Oct 16. pii: 5588579. doi: 10.1093.
    PubMed     Abstract available


  310. ELGHAIEB H, Tedim AP, Abbassi MS, Novais C, et al
    From farm to fork: identical clones and Tn6674-like elements in linezolid-resistant Enterococcus faecalis from food-producing animals and retail meat.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585955. doi: 10.1093.
    PubMed     Abstract available


  311. NISHIMOTO AT, Sharma C, Rogers PD
    Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
    J Antimicrob Chemother. 2019 Oct 11. pii: 5585656. doi: 10.1093.
    PubMed     Abstract available


  312. MELLO SS, Van Tyne D, Lebreton F, Silva SQ, et al
    A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.
    J Antimicrob Chemother. 2019 Oct 5. pii: 5581810. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  313. WARDENBURG KE, Potter RF, D'Souza AW, Hussain T, et al
    Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.
    J Antimicrob Chemother. 2019 Aug 23. pii: 5553751. doi: 10.1093.
    PubMed     Abstract available


  314. BOJANG A, Baines SL, Donovan L, Guerillot R, et al
    Genomic investigation of Staphylococcus aureus recovered from Gambian women and newborns following an oral dose of intra-partum azithromycin.
    J Antimicrob Chemother. 2019 Aug 19. pii: 5551401. doi: 10.1093.
    PubMed     Abstract available


  315. FULLER J, Dingle TC, Bull A, Shokoples S, et al
    Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
    J Antimicrob Chemother. 2019;74.
    PubMed     Abstract available


    July 2019
  316. KLARE I, Bender JK, Fleige C, Kriebel N, et al
    Comparison of VITEK(R) 2, three different gradient strip tests and broth microdilution for detecting vanB-positive Enterococcus faecium isolates with low vancomycin MICs.
    J Antimicrob Chemother. 2019 Jul 23. pii: 5537362. doi: 10.1093.
    PubMed     Abstract available


  317. SHANG Y, Li D, Hao W, Schwarz S, et al
    A prophage and two ICESa2603-family integrative and conjugative elements (ICEs) carrying optrA in Streptococcus suis.
    J Antimicrob Chemother. 2019 Jul 17. pii: 5533309. doi: 10.1093.
    PubMed     Abstract available


  318. PI R, Liu Q, Jiang Q, Gao Q, et al
    Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS.
    J Antimicrob Chemother. 2019;74:1795-1798.
    PubMed     Abstract available


  319. GONZALEZ-LARA MF, Roman-Montes CM, Diaz-Lomeli P, Rangel-Cordero A, et al
    Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    J Antimicrob Chemother. 2019;74:2047-2050.
    PubMed     Abstract available


    June 2019
  320. ELGHAIEB H, Freitas AR, Abbassi MS, Novais C, et al
    Dispersal of linezolid-resistant enterococci carrying poxtA or optrA in retail meat and food-producing animals from Tunisia.
    J Antimicrob Chemother. 2019 Jun 26. pii: 5523711. doi: 10.1093.
    PubMed     Abstract available


  321. RESENDIZ-SHARPE A, Mercier T, Lestrade PPA, van der Beek MT, et al
    Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    J Antimicrob Chemother. 2019 Jun 24. pii: 5522515. doi: 10.1093.
    PubMed     Abstract available


  322. LEON-SAMPEDRO R, Fernandez-de-Bobadilla MD, San Millan A, Baquero F, et al
    Transfer dynamics of Tn6648, a composite integrative conjugative element generated by tandem accretion of Tn5801 and Tn6647 in Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Jun 21. pii: 5521775. doi: 10.1093.
    PubMed     Abstract available


  323. SHEN P, Zhou K, Wang Y, Song J, et al
    High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    J Antimicrob Chemother. 2019 Jun 15. pii: 5519372. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  324. MORIO F, Lombardi L, Binder U, Loge C, et al
    Precise genome editing using a CRISPR-Cas9 method highlights the role of CoERG11 amino acid substitutions in azole resistance in Candida orthopsilosis.
    J Antimicrob Chemother. 2019 May 18. pii: 5491491. doi: 10.1093.
    PubMed     Abstract available


  325. REED JM, Gardner SG, Mishra NN, Bayer AS, et al
    Metabolic interventions for the prevention and treatment of daptomycin non-susceptibility in Staphylococcus aureus.
    J Antimicrob Chemother. 2019 May 10. pii: 5487738. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  326. LAVERGNE RA, Morio F, Danner-Boucher I, Horeau-Langlard D, et al
    One year prospective survey of azole resistance in Aspergillus fumigatus at a French cystic fibrosis reference centre: prevalence and mechanisms of resistance.
    J Antimicrob Chemother. 2019 Apr 30. pii: 5481886. doi: 10.1093.
    PubMed     Abstract available


  327. PAPAGIANNITSIS CC, Tsilipounidaki K, Malli E, Petinaki E, et al
    Detection in Greece of a clinical Enterococcus faecium isolate carrying the novel oxazolidinone resistance gene poxtA.
    J Antimicrob Chemother. 2019 Apr 22. pii: 5476265. doi: 10.1093.
    PubMed    


    March 2019
  328. SASSI M, Guerin F, Zouari A, Beyrouthy R, et al
    Emergence of optrA-mediated linezolid resistance in enterococci from France, 2006-16.
    J Antimicrob Chemother. 2019 Mar 20. pii: 5416192. doi: 10.1093.
    PubMed     Abstract available


  329. HAO W, Shan X, Li D, Schwarz S, et al
    Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.
    J Antimicrob Chemother. 2019 Mar 19. pii: 5396705. doi: 10.1093.
    PubMed     Abstract available


  330. HASMAN H, Clausen PTLC, Kaya H, Hansen F, et al
    LRE-Finder, a Web tool for detection of the 23S rRNA mutations and the optrA, cfr, cfr(B) and poxtA genes encoding linezolid resistance in enterococci from whole-genome sequences.
    J Antimicrob Chemother. 2019 Mar 12. pii: 5377356. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  331. FARHAT MR, Sixsmith J, Calderon R, Hicks ND, et al
    Rifampicin and rifabutin resistance in 1003 Mycobacterium tuberculosis clinical isolates.
    J Antimicrob Chemother. 2019 Feb 21. pii: 5359497. doi: 10.1093.
    PubMed     Abstract available


  332. SINGH A, Singh PK, de Groot T, Kumar A, et al
    Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India.
    J Antimicrob Chemother. 2019 Feb 11. pii: 5315659. doi: 10.1093.
    PubMed     Abstract available


  333. WU T, Meyer K, Harrington AT, Danziger LH, et al
    In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.
    J Antimicrob Chemother. 2019 Feb 8. pii: 5310330. doi: 10.1093.
    PubMed     Abstract available


  334. PAUL S, Singh S, Chakrabarti A, Rudramurthy SM, et al
    Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis.
    J Antimicrob Chemother. 2019 Feb 6. pii: 5307967. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  335. KITAMURA M, Kimura K, Ido A, Seki T, et al
    Relatively high rates of cefotaxime- and ceftriaxone-non-susceptible isolates among group B streptococci with reduced penicillin susceptibility (PRGBS) in Japan.
    J Antimicrob Chemother. 2019 Jan 11. pii: 5288581. doi: 10.1093.
    PubMed     Abstract available


  336. MORRONI G, Brenciani A, Litta-Mulondo A, Vignaroli C, et al
    Characterization of a new transferable MDR plasmid carrying the pbp5 gene from a clade B commensal Enterococcus faecium.
    J Antimicrob Chemother. 2019 Jan 10. pii: 5288148. doi: 10.1093.
    PubMed     Abstract available


    December 2018
  337. MACFADYEN AC, Harrison EM, Drigo I, Parkhill J, et al
    A mecC allotype, mecC3, in the CoNS Staphylococcus caeli, encoded within a variant SCCmecC.
    J Antimicrob Chemother. 2018 Dec 22. pii: 5258045. doi: 10.1093.
    PubMed     Abstract available


  338. RYBAK JM, Fortwendel JR, Rogers PD
    Emerging threat of triazole-resistant Aspergillus fumigatus.
    J Antimicrob Chemother. 2018 Dec 17. pii: 5250853. doi: 10.1093.
    PubMed     Abstract available


  339. ACCOCEBERRY I, Couzigou C, Fitton-Ouhabi V, Biteau N, et al
    Challenging SNP impact on caspofungin resistance by full-length FKS1 allele replacement in Candida lusitaniae.
    J Antimicrob Chemother. 2018 Dec 4. pii: 5230873. doi: 10.1093.
    PubMed     Abstract available


  340. AKKERMAN OW, Alffenaar JWC
    Comment on: The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosis.
    J Antimicrob Chemother. 2018 Dec 1. pii: 5224542. doi: 10.1093.
    PubMed    


    October 2018
  341. LOPEZ B, Siqueira de Oliveira R, Pinhata JMW, Chimara E, et al
    Bedaquiline and linezolid MIC distributions and epidemiological cut-off values for Mycobacterium tuberculosis in the Latin American region.
    J Antimicrob Chemother. 2018 Oct 25. pii: 5144701. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: